-
2023/11/14
- Financial Results and Presentation Materials for the 1st Quarter of the Fiscal Year ending June 2024
-
2023/11/02
- Notice Regarding a definitive distribution agreement for the Exclusive Sales of Penumbra’s Peripheral Vascular Thrombus Aspiration Device in the Japanese Market
-
2023/10/31
- Notice Regarding Establishment of Joint Venture Company (Subsidiary) with ELDORET HOSPITAL LTD
-
2023/10/24
- Participation in COMPAMED in November 2023
-
2023/10/04
- Additional Agreement on Joint Research Agreement with Cuorips Inc.
-
2023/11/14
- Financial Results and Presentation Materials for the 1st Quarter of the Fiscal Year ending June 2024
-
2023/11/02
- Notice Regarding a definitive distribution agreement for the Exclusive Sales of Penumbra’s Peripheral Vascular Thrombus Aspiration Device in the Japanese Market
-
2023/10/31
- Notice Regarding Establishment of Joint Venture Company (Subsidiary) with ELDORET HOSPITAL LTD
-
2023/10/04
- Additional Agreement on Joint Research Agreement with Cuorips Inc.
-
2023/09/29
- Notice Regarding Publication of Asahi Intecc Group “Integrated Report 2023″
-
2023/10/24
- Participation in COMPAMED in November 2023
-
2023/08/28
- Participation in Medical Technology Ireland in Sep 2023
-
2022/11/07
- Participation in ICI in November 2022
-
2022/10/28
- Participation in CMEF held in Shenzhen, China in Nov 2022
-
2022/10/14
- Participation in COMPAMED in November 2022
